NCT07222111

Brief Summary

Prior studies have shown that dietary supplementation with dried plums (also known as prunes) reduces bone loss in postmenopausal women. The purpose of this clinical trial is to understand how dried plums mediate their effects on bone. The main questions the study will answer are:

  1. 1.Does adding dried plums to the diet alter immune cell function?
  2. 2.Does dried plum alter gut microbes?
  3. 3.Does a person's vitamin D status influence this response?
  4. 4.Consume their normal diet or supplement their normal diet dried plums for four week periods over the course of 3-4 months.
  5. 5.Complete 5 study visits scheduled.
  6. 6.Perform some physical function tests and have a bone density scan at the beginning of the study.
  7. 7.Complete questionnaires, a 3-day food record, and provide stool and blood samples at 4 different timepoints during the study.
  8. 8.Record information about their bowel habits

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
28mo left

Started Sep 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Sep 2025Aug 2028

First Submitted

Initial submission to the registry

September 1, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

September 2, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 29, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2028

Last Updated

October 29, 2025

Status Verified

September 1, 2025

Enrollment Period

2 years

First QC Date

September 1, 2025

Last Update Submit

October 27, 2025

Conditions

Keywords

immune systemdried plumsprebioticsT cellsbone healthvitamin D

Outcome Measures

Primary Outcomes (3)

  • Change in Circulating T Helper (Th)17 Cells

    Change in the relative abundance of circulating Th17 cells in response to dried plum supplementation compared to control arm of the study will be reported.

    Change from baseline to the end of each 4-week arm of the study

  • Ex Vivo T Cell Function

    Ex vivo experiements will be performed with peripheral blood mononuclear cells (PBMCs) collected at the final time points of each of the two arms (4 weeks in duration) of the study. Cells will be challenged and the release of interleukin 17 and interleukin 10 will be assessed in the media. The cytokine response of cells collected at the end of the control or dried plum treatment arm arm will be assessed.

    The end of each 4 week arm of the study

  • Treatment Effects on Serum IL-6

    Serum IL-6 will be compared at the end of the control arm and at the end of dried plum supplementation arm of the study.

    End of the 4-week control and dried plum treatment arm of the study.

Secondary Outcomes (8)

  • Change in Circulating T Regulatory Cells

    Change from baseline to the end of each 4-week arm of the study

  • Change in the Treg to Th17 ratio

    The change from baseline until final time points of each arm of each 4-week arm of the study.

  • Ex Vivo T Cell TNF-a

    Sample collected at the end of each 4-week arm of the study

  • Change in Serum Metabolites

    The change from baseline until final time points of each arm of each 4-week arm of the study.

  • Change in Fecal Metabolites

    The change from baseline until final time points of each arm of each 4-week arm of the study.

  • +3 more secondary outcomes

Other Outcomes (3)

  • Dietary Assessment

    Baseline and at the completion of each 4-week arm of the study.

  • Physical Activity Assessment

    Prior to and at the completion of each 4-week arm of the study

  • Body weight

    Prior to and at the completion of each 4-week study arm

Study Arms (2)

Dried Plum

EXPERIMENTAL

Participants will consume their usual diet supplemented with 50 g of dried plum (5-6 dried plums) per day.

Dietary Supplement: Dried plums

Regular Diet

NO INTERVENTION

Participants will consume their usual diet.

Interventions

Dried plumsDIETARY_SUPPLEMENT

Participants will supplement their regular diet with 50 g of dried plum (5-6 dried plums) per day.

Dried Plum

Eligibility Criteria

Age60 Years - 75 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women 60-75 years of age at the start of the study;
  • or more consecutive months without a menstrual period;
  • willing to include dried plums in their daily diet and collect fecal samples at four time points;
  • ambulatory without assistance;
  • capacity to give informed consent.

You may not qualify if:

  • women who have been on medications known to alter bone or calcium metabolism (e.g., oral bisphosphonates, raloxifene, denosumab, intermittent parathyroid hormone, growth hormone) within 12 months of starting the study. Prior use of intravenous bisphosphonates at any time.
  • women who have been on hormone replacement therapy, steroids (i.e., glucocorticoids), biologics, or chronic NSAID within 3 months of starting the study.
  • women with a previous diagnosis of osteoporosis (i.e., BMD T-score or history of vertebral fracture or fragility fractures of hip, wrist, humerus after the age of 50 yr) or other metabolic bone disease (e.g., osteomalacia or osteogenesis imperfect), renal disease, stroke, heart attack, type 2 diabetes, liver disease or autoimmune diseases (e.g., rheumatoid arthritis, systemic Lupus erythematosus, type 1 diabetes mellitus, IBD) that could affect bone metabolism or T cell biology will be excluded.
  • women who have undergone treatment for cancer within 12 months of starting the study
  • women who have been taking prebiotic or probiotic supplements or natural products that have estrogen-like effects in the past 3 months
  • women who smoke, have a BMI \>40 kg/m2 or \<18.5 kg/m2, or consume \>2 alcoholic drinks per day
  • women who regularly consume dried plums or prune juice (\>1 serving weekly).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IU Health University Hospital Clinical Research Center

Indianapolis, Indiana, 46202, United States

RECRUITING

Related Publications (3)

  • Hooshmand S, Kern M, Metti D, Shamloufard P, Chai SC, Johnson SA, Payton ME, Arjmandi BH. The effect of two doses of dried plum on bone density and bone biomarkers in osteopenic postmenopausal women: a randomized, controlled trial. Osteoporos Int. 2016 Jul;27(7):2271-2279. doi: 10.1007/s00198-016-3524-8. Epub 2016 Feb 22.

    PMID: 26902092BACKGROUND
  • Hooshmand S, Chai SC, Saadat RL, Payton ME, Brummel-Smith K, Arjmandi BH. Comparative effects of dried plum and dried apple on bone in postmenopausal women. Br J Nutr. 2011 Sep;106(6):923-30. doi: 10.1017/S000711451100119X. Epub 2011 May 31.

    PMID: 21736808BACKGROUND
  • De Souza MJ, Strock NCA, Williams NI, Lee H, Koltun KJ, Rogers C, Ferruzzi MG, Nakatsu CH, Weaver C. Prunes preserve hip bone mineral density in a 12-month randomized controlled trial in postmenopausal women: the Prune Study. Am J Clin Nutr. 2022 Oct 6;116(4):897-910. doi: 10.1093/ajcn/nqac189.

    PMID: 35798020BACKGROUND

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: The two study arms are normal diet (control) or normal diet supplemented with dried plum (intervention).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Vice-chair of Translational Research in OBGYN

Study Record Dates

First Submitted

September 1, 2025

First Posted

October 29, 2025

Study Start

September 2, 2025

Primary Completion (Estimated)

August 30, 2027

Study Completion (Estimated)

August 30, 2028

Last Updated

October 29, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

As described above, the compiled data will be kept in the IU's institutional repository, IU ScholarWorks. Deposition of (de-identified) data in this system creates a DOI that will be used in publications to facilitate discovery. We will share metadata as well as participant data associated with the study. Data will be made available to investigators with PD permission and consistent with the USDA and the university guidelines. Data will be deposited in the IU ScholarWorks and embargoed for one year after the completion of the study. We will provide the names and institutions of persons who were either given or denied access to the data, and the bases for such decisions will be included in the annual progress report.

Shared Documents
STUDY PROTOCOL
Time Frame
August 2029
Access Criteria
Investigators with PI permission

Locations